Delivery Order SPE2DB20D3103-SPE2DB25FN8W7

Award Date 5/20/25
Potential Completion Date 5/21/25
Potential Value $6.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, with a ceiling value of $16,934.32 and a performance period ending on May 20, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,934.96, is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product. It is a firm fixed-price contract with a period of performance through February 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,011.57, is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through November 22, 2023. The contract does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a medication product, with a ceiling value of $10,430.71 and a period of performance through May 22, 2025. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,401.57, is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract is a firm-fixed price delivery order, with a period of performance through March 6, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a ceiling value of $7,214.80 and a period of performance through March 6, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a medical product, with a ceiling value of $6,940.87 and a period of performance through April 1, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,480.07 firm fixed-price contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a prescription medication, with a period of performance ending on May 19, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,896.70 firm fixed-price contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The contract has an ultimate completion date of May 20, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,349.64, is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a prescription medication. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation,...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FN8W7
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,716.68, is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, with a performance period extending to May 21, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely part of the company's broader role as a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/24/25, 1:09 AM